Daniel Thayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Thayer has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Sue Jordan
Swansea University
3 shared publications Caroline Brooks
SAIL Databank, Swansea University Medical School, Swansea, United Kingdom
2 shared publicationsHuw Collins
SAIL Databank, Swansea University Medical School, Swansea, United Kingdom
2 shared publications- Rachel A. Charlton
Department of Life Sciences, University of Bath, Bath, UK
2 shared publications A Puccini
Drug Policy Service, Emilia Romagna Region Health Authority, Bologna, Italy
1 shared publicationA. Engeland
Department of Pharmacoepidemiology, The Norwegian Institute of Public Health, Oslo, Norway
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1005050
Associations of major congenital anomalies, long-term health conditions, and socioeconomic deprivation with educational attainment in Wales: A population-based data linkage study
Background: Education outcomes are associated with life chances. However, deprivation, ill-health and disability are barriers to achievement. We aimed to investigate educational attainment of children with and without major congenital anomalies in state-funded mainstream schools at ages 11 and 16 (key stages [KS] 2 and 4), accounting for maternal and child socioeconomic deprivation, demographic factors, comorbidities, and special education needs (SEN) provision. Methods and findings: We conducted a retrospective population-based cohort study using the Secure Anonymised Information Linkage (SAIL) Databank to link routinely collected electronic health and education records of children born in Wales between January 1st, 1998 and December 31st, 2007, who were followed up until December 31st, 2019. Education outcomes were explored using logistic regression, adjusting for: major congenital anomalies, maternal and child socioeconomic deprivation, medicated co-morbidities, hospitalisation, gestation length, child sex, year of birth, and SEN provision. Children with major congenital anomalies were less likely to achieve national academic standards, including those required for some professional courses: however, attainment was more strongly associated with socioeconomic deprivation. At age 11, 81.9% (7167/8754) with and 93.8% (232,450/247,814) without major congenital anomalies attained established standards (odds ratio [OR] 0.30; 95% confidence intervals [CI] [0.28,0.32]). At age 16, 46.8% (2070/4427) with and 56.1% (69,732/124,300) without major congenital anomalies achieved 5 General Certificates of Secondary Education (GCSEs) at grades C–A*, including English/Welsh, Maths and Science (EWMS) (OR 0.69; 95% CI [0.65,0.73]). Discrepancies narrowed in adjusted analyses, particularly when SEN provision was accounted: aOR 0.72; 95% CI [0.66,0.78] at KS2, age 11, and aOR 0.93; 95% CI [0.87,1.00] for 5 GCSEs C–A* with EWMS. These GCSEs were achieved by 29.7% (307/1034) children with major congenital anomalies and 38.4% (10,875/28,305) of unaffected children in the most deprived quintile (using maternal Welsh Index of Multiple Deprivation: in the least deprived quintile, figures were 67.6% (547/810) and 75.0% (16,978/22,644), respectively. Children with major congenital anomalies, receiving maximum SEN support, and eligible for Free School Meals (FSM) were the least likely to achieve national academic standards: 5/192 (2.6%) obtained 5 GCSEs C–A* with EWMS, as did 37/354 (10.4%) ineligible for FSM. The strongest associations with 5 GCSEs C–A* with EWMS, were SEN statements (aOR 0.07; 95% CI [0.06,0.07]), FSM eligibility (aOR 0.39; 95% CI [0.37,0.41]), and epilepsy (aOR 0.60; 95% CI [0.45,0.80]). Study limitations included absence of data for 15%–18% of children, mainly those educated outside mainstream schools, and for some comorbidities; generalisation of findings to other settings or other countries is uncertain. Conclusions: Many children with major congenital anomalies from least deprived quintiles attained national academic standards, including 5 GCSEs C–A* with EWMS. The children living in the most deprived quintiles or eligible for FSM and with ill-health from major congenital anomalies and/or epilepsy were two to four times less likely to attain these standards. SEN provision mitigated the associations with disadvantage, but children from socioeconomically deprived quintiles with major congenital anomalies were unlikely to achieve 5 GCSEs C–A* with EWMS.
- 16 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1005050
Open AccessAssociations of major congenital anomalies, long-term health conditions, and socioeconomic deprivation with educational attainment in Wales: A population-based data linkage study
Background: Education outcomes are associated with life chances. However, deprivation, ill-health and disability are barriers to achievement. We aimed to investigate educational attainment of children with and without major congenital anomalies in state-funded mainstream schools at ages 11 and 16 (key stages [KS] 2 and 4), accounting for maternal and child socioeconomic deprivation, demographic factors, comorbidities, and special education needs (SEN) provision. Methods and findings: We conducted a retrospective population-based cohort study using the Secure Anonymised Information Linkage (SAIL) Databank to link routinely collected electronic health and education records of children born in Wales between January 1st, 1998 and December 31st, 2007, who were followed up until December 31st, 2019. Education outcomes were explored using logistic regression, adjusting for: major congenital anomalies, maternal and child socioeconomic deprivation, medicated co-morbidities, hospitalisation, gestation length, child sex, year of birth, and SEN provision. Children with major congenital anomalies were less likely to achieve national academic standards, including those required for some professional courses: however, attainment was more strongly associated with socioeconomic deprivation. At age 11, 81.9% (7167/8754) with and 93.8% (232,450/247,814) without major congenital anomalies attained established standards (odds ratio [OR] 0.30; 95% confidence intervals [CI] [0.28,0.32]). At age 16, 46.8% (2070/4427) with and 56.1% (69,732/124,300) without major congenital anomalies achieved 5 General Certificates of Secondary Education (GCSEs) at grades C–A*, including English/Welsh, Maths and Science (EWMS) (OR 0.69; 95% CI [0.65,0.73]). Discrepancies narrowed in adjusted analyses, particularly when SEN provision was accounted: aOR 0.72; 95% CI [0.66,0.78] at KS2, age 11, and aOR 0.93; 95% CI [0.87,1.00] for 5 GCSEs C–A* with EWMS. These GCSEs were achieved by 29.7% (307/1034) children with major congenital anomalies and 38.4% (10,875/28,305) of unaffected children in the most deprived quintile (using maternal Welsh Index of Multiple Deprivation: in the least deprived quintile, figures were 67.6% (547/810) and 75.0% (16,978/22,644), respectively. Children with major congenital anomalies, receiving maximum SEN support, and eligible for Free School Meals (FSM) were the least likely to achieve national academic standards: 5/192 (2.6%) obtained 5 GCSEs C–A* with EWMS, as did 37/354 (10.4%) ineligible for FSM. The strongest associations with 5 GCSEs C–A* with EWMS, were SEN statements (aOR 0.07; 95% CI [0.06,0.07]), FSM eligibility (aOR 0.39; 95% CI [0.37,0.41]), and epilepsy (aOR 0.60; 95% CI [0.45,0.80]). Study limitations included absence of data for 15%–18% of children, mainly those educated outside mainstream schools, and for some comorbidities; generalisation of findings to other settings or other countries is uncertain. Conclusions: Many children with major congenital anomalies from least deprived quintiles attained national academic standards, including 5 GCSEs C–A* with EWMS. The children living in the most deprived quintiles or eligible for FSM and with ill-health from major congenital anomalies and/or epilepsy were two to four times less likely to attain these standards. SEN provision mitigated the associations with disadvantage, but children from socioeconomically deprived quintiles with major congenital anomalies were unlikely to achieve 5 GCSEs C–A* with EWMS.
- Open Access
- 13 April 2023
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 3 (3) , oead037
SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S4-BOW-AF)
In patients with non-valvular atrial fibrillation (NVAF) prescribed warfarin, the association between guideline defined international normalised ratio (INR) control and adverse outcomes in unknown. We aimed to (i) determine stroke and systemic embolism (SSE) and bleeding events in NVAF patients prescribed warfarin; and (ii) estimate the increased risk of these adverse events associated with poor INR control in this population. Individual-level population-scale linked patient data were used to investigate the association between INR control and both SSE and bleeding events using (i) the National Institute for Health and Care Excellence (NICE) criteria of poor INR control [time in therapeutic range (TTR) 8]. A total of 35 891 patients were included for SSE and 35 035 for bleeding outcome analyses. Mean CHA2DS2-VASc score was 3.5 (SD = 1.7), and the mean follow up was 4.3 years for both analyses. Mean TTR was 71.9%, with 34% of time spent in poor INR control according to NICE criteria. SSE and bleeding event rates (per 100 patient years) were 1.01 (95%CI 0.95–1.08) and 3.4 (95%CI 3.3–3.5), respectively, during adequate INR control, rising to 1.82 (95%CI 1.70–1.94) and 4.8 (95% CI 4.6–5.0) during poor INR control. Poor INR control was independently associated with increased risk of both SSE [HR = 1.69 (95%CI = 1.54–1.86), P < 0.001] and bleeding [HR = 1.40 (95%CI 1.33–1.48), P < 0.001] in Cox-multivariable models. Guideline-defined poor INR control is associated with significantly higher SSE and bleeding event rates, independent of recognised risk factors for stroke or bleeding.
- 13 April 2023
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 3 (3) , oead037
Open AccessSAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S4-BOW-AF)
In patients with non-valvular atrial fibrillation (NVAF) prescribed warfarin, the association between guideline defined international normalised ratio (INR) control and adverse outcomes in unknown. We aimed to (i) determine stroke and systemic embolism (SSE) and bleeding events in NVAF patients prescribed warfarin; and (ii) estimate the increased risk of these adverse events associated with poor INR control in this population. Individual-level population-scale linked patient data were used to investigate the association between INR control and both SSE and bleeding events using (i) the National Institute for Health and Care Excellence (NICE) criteria of poor INR control [time in therapeutic range (TTR) 8]. A total of 35 891 patients were included for SSE and 35 035 for bleeding outcome analyses. Mean CHA2DS2-VASc score was 3.5 (SD = 1.7), and the mean follow up was 4.3 years for both analyses. Mean TTR was 71.9%, with 34% of time spent in poor INR control according to NICE criteria. SSE and bleeding event rates (per 100 patient years) were 1.01 (95%CI 0.95–1.08) and 3.4 (95%CI 3.3–3.5), respectively, during adequate INR control, rising to 1.82 (95%CI 1.70–1.94) and 4.8 (95% CI 4.6–5.0) during poor INR control. Poor INR control was independently associated with increased risk of both SSE [HR = 1.69 (95%CI = 1.54–1.86), P < 0.001] and bleeding [HR = 1.40 (95%CI 1.33–1.48), P < 0.001] in Cox-multivariable models. Guideline-defined poor INR control is associated with significantly higher SSE and bleeding event rates, independent of recognised risk factors for stroke or bleeding.
- Open Access
- 11 September 2021
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 10 (9)
Desiderata for the development of next-generation electronic health record phenotype libraries
Background: High-quality phenotype definitions are desirable to enable the extraction of patient cohorts from large electronic health record repositories and are characterized by properties such as portability, reproducibility, and validity. Phenotype libraries, where definitions are stored, have the potential to contribute significantly to the quality of the definitions they host. In this work, we present a set of desiderata for the design of a next-generation phenotype library that is able to ensure the quality of hosted definitions by combining the functionality currently offered by disparate tooling.Methods: A group of researchers examined work to date on phenotype models, implementation, and validation, as well as contemporary phenotype libraries developed as a part of their own phenomics communities. Existing phenotype frameworks were also examined. This work was translated and refined by all the authors into a set of best practices.Results: We present 14 library desiderata that promote high-quality phenotype definitions, in the areas of modelling, logging, validation, and sharing and warehousing.Conclusions: There are a number of choices to be made when constructing phenotype libraries. Our considerations distil the best practices in the field and include pointers towards their further development to support portable, reproducible, and clinically valid phenotype design. The provision of high-quality phenotype definitions enables electronic health record data to be more effectively used in medical domains.
- 11 September 2021
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 10 (9)
Open AccessDesiderata for the development of next-generation electronic health record phenotype libraries
Background: High-quality phenotype definitions are desirable to enable the extraction of patient cohorts from large electronic health record repositories and are characterized by properties such as portability, reproducibility, and validity. Phenotype libraries, where definitions are stored, have the potential to contribute significantly to the quality of the definitions they host. In this work, we present a set of desiderata for the design of a next-generation phenotype library that is able to ensure the quality of hosted definitions by combining the functionality currently offered by disparate tooling.Methods: A group of researchers examined work to date on phenotype models, implementation, and validation, as well as contemporary phenotype libraries developed as a part of their own phenomics communities. Existing phenotype frameworks were also examined. This work was translated and refined by all the authors into a set of best practices.Results: We present 14 library desiderata that promote high-quality phenotype definitions, in the areas of modelling, logging, validation, and sharing and warehousing.Conclusions: There are a number of choices to be made when constructing phenotype libraries. Our considerations distil the best practices in the field and include pointers towards their further development to support portable, reproducible, and clinically valid phenotype design. The provision of high-quality phenotype definitions enables electronic health record data to be more effectively used in medical domains.
- Open Access
- 11 February 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228545
Measuring follow-up time in routinely-collected health datasets: Challenges and solutions
A key requirement for longitudinal studies using routinely-collected health data is to be able to measure what individuals are present in the datasets used, and over what time period. Individuals can enter and leave the covered population of administrative datasets for a variety of reasons, including both life events and characteristics of the datasets themselves. An automated, customizable method of determining individuals’ presence was developed for the primary care dataset in Swansea University’s SAIL Databank. The primary care dataset covers only a portion of Wales, with 76% of practices participating. The start and end date of the data varies by practice. Additionally, individuals can change practices or leave Wales. To address these issues, a two step process was developed. First, the period for which each practice had data available was calculated by measuring changes in the rate of events recorded over time. Second, the registration records for each individual were simplified. Anomalies such as short gaps and overlaps were resolved by applying a set of rules. The result of these two analyses was a cleaned set of records indicating start and end dates of available primary care data for each individual. Analysis of GP records showed that 91.0% of events occurred within periods calculated as having available data by the algorithm. 98.4% of those events were observed at the same practice of registration as that computed by the algorithm. A standardized method for solving this common problem has enabled faster development of studies using this data set. Using a rigorous, tested, standardized method of verifying presence in the study population will also positively influence the quality of research.
- 11 February 2020
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (2) , e0228545
Open AccessMeasuring follow-up time in routinely-collected health datasets: Challenges and solutions
A key requirement for longitudinal studies using routinely-collected health data is to be able to measure what individuals are present in the datasets used, and over what time period. Individuals can enter and leave the covered population of administrative datasets for a variety of reasons, including both life events and characteristics of the datasets themselves. An automated, customizable method of determining individuals’ presence was developed for the primary care dataset in Swansea University’s SAIL Databank. The primary care dataset covers only a portion of Wales, with 76% of practices participating. The start and end date of the data varies by practice. Additionally, individuals can change practices or leave Wales. To address these issues, a two step process was developed. First, the period for which each practice had data available was calculated by measuring changes in the rate of events recorded over time. Second, the registration records for each individual were simplified. Anomalies such as short gaps and overlaps were resolved by applying a set of rules. The result of these two analyses was a cleaned set of records indicating start and end dates of available primary care data for each individual. Analysis of GP records showed that 91.0% of events occurred within periods calculated as having available data by the algorithm. 98.4% of those events were observed at the same practice of registration as that computed by the algorithm. A standardized method for solving this common problem has enabled faster development of studies using this data set. Using a rigorous, tested, standardized method of verifying presence in the study population will also positively influence the quality of research.
- Open Access
- 21 November 2019
- Published by Swansea University in International Journal of Population Data Science
- Vol. 4 (3)
Repeatable Research Infrastructure Enabling Administrative Data Analysis
Background/RationaleLinked administrative datasets offer great potential for research, but also present major challenges—including the preparation of operational data into a form suitable for efficient research, complex and computationally demanding analysis, and the need to capture and share information about dataset contents and research methods. Main AimThe analytical services team in the Secure Anonymised Information Linkage (SAIL) Databank is creating interconnected tools and systems to automate the preparation and analysis of research data and to curate information about datasets and research methods. Our underlying goal is to make linked data research orders of magnitude faster and cheaper, as well as improve its consistency and quality. MethodsSeveral key developments are ongoing: Automation of data quality checking. Management of dataset metadata. Processing of raw source datasets into cleaned, research-ready data assets. The Concept Library, an application for creating, using, and sharing knowledge about research definitions and methods. A suite of R packages for analysis. Web Application Programming Interfaces will allow these pieces to work together as an integrated system enabling efficient research. ResultsInitial versions of dataset quality checking, cleaned datasets, and R code to implement common tasks are already in day-to-day use by researchers within SAIL. An advisory group has been convened to help guide the work. For example, shared library code that flags conditions within health data has been used across multiple projects; a cleaned dataset measuring follow-up within primary care has been used by more than 100 projects. ConclusionOur proof-of-concept work demonstrates the ability of shared code and cleaned data to meet needs across multiple projects, saving effort and standardizing results. Ongoing work to develop and integrate these tools should further streamline the research process, increasing the output and public benefit of SAIL and other data sources.
- 21 November 2019
- Published by Swansea University in International Journal of Population Data Science
- Vol. 4 (3)
Open AccessRepeatable Research Infrastructure Enabling Administrative Data Analysis
Background/RationaleLinked administrative datasets offer great potential for research, but also present major challenges—including the preparation of operational data into a form suitable for efficient research, complex and computationally demanding analysis, and the need to capture and share information about dataset contents and research methods. Main AimThe analytical services team in the Secure Anonymised Information Linkage (SAIL) Databank is creating interconnected tools and systems to automate the preparation and analysis of research data and to curate information about datasets and research methods. Our underlying goal is to make linked data research orders of magnitude faster and cheaper, as well as improve its consistency and quality. MethodsSeveral key developments are ongoing: Automation of data quality checking. Management of dataset metadata. Processing of raw source datasets into cleaned, research-ready data assets. The Concept Library, an application for creating, using, and sharing knowledge about research definitions and methods. A suite of R packages for analysis. Web Application Programming Interfaces will allow these pieces to work together as an integrated system enabling efficient research. ResultsInitial versions of dataset quality checking, cleaned datasets, and R code to implement common tasks are already in day-to-day use by researchers within SAIL. An advisory group has been convened to help guide the work. For example, shared library code that flags conditions within health data has been used across multiple projects; a cleaned dataset measuring follow-up within primary care has been used by more than 100 projects. ConclusionOur proof-of-concept work demonstrates the ability of shared code and cleaned data to meet needs across multiple projects, saving effort and standardizing results. Ongoing work to develop and integrate these tools should further streamline the research process, increasing the output and public benefit of SAIL and other data sources.
- Open Access
- 1 April 2019
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 7 (4) , 278-287
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study
- 1 April 2019
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 7 (4) , 278-287
Open AccessPrimary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study
- Open Access
- 6 February 2019
- Published by Wiley in Pediatric Diabetes
- Vol. 20 (3) , 330-338
Presentation to primary care during the prodrome of type 1 diabetes in childhood: A case‐control study using record data linkage
Objective To evaluate primary care presentations during the prodrome (12 months prior to onset‐Type 1 diabetes, with or without DKA), to identify opportunities for earlier diagnosis. Methods This was a case‐control study, linking 16 years of data from children (≤15 years) registered at diagnosis of Type 1 diabetes, and routinely collected primary care records in Wales (UK). Controls (without Type 1 diabetes) were matched on a 3:1 ratio. Conditional logistic regression modelling was used to compare characteristics occurring in cases (children with Type 1 diabetes) and controls; and cases that presented with/without DKA. Results 1345 children with Type 1 diabetes (19% DKA) and 4035 controls were identified. During the 12 months prior to diagnosis, cases were 6.5 times more likely to have at least one primary care contact (p <0.001). One to 30 days prior to diagnosis, contacts relating to blood tests, fungal conditions, respiratory tract infections, urinary conditions, vomiting, and weight were independently associated with Type 1 diabetes, as were contacts relating to blood tests, between 91 and 180 days prior to diagnosis. Children with a contact up to a month prior to diagnosis, relating to respiratory tract infections, antibiotic prescriptions, and vomiting, were more likely to present in DKA, as were boys (p = 0.047). Conclusion There are opportunities in primary care for an earlier diagnosis of Type 1 diabetes in childhood. These data could be used to create a predictive diagnostic tool, as a potential aid for primary care health professionals, to prevent presentation in DKA.
- 6 February 2019
- Published by Wiley in Pediatric Diabetes
- Vol. 20 (3) , 330-338
Open AccessPresentation to primary care during the prodrome of type 1 diabetes in childhood: A case‐control study using record data linkage
Objective To evaluate primary care presentations during the prodrome (12 months prior to onset‐Type 1 diabetes, with or without DKA), to identify opportunities for earlier diagnosis. Methods This was a case‐control study, linking 16 years of data from children (≤15 years) registered at diagnosis of Type 1 diabetes, and routinely collected primary care records in Wales (UK). Controls (without Type 1 diabetes) were matched on a 3:1 ratio. Conditional logistic regression modelling was used to compare characteristics occurring in cases (children with Type 1 diabetes) and controls; and cases that presented with/without DKA. Results 1345 children with Type 1 diabetes (19% DKA) and 4035 controls were identified. During the 12 months prior to diagnosis, cases were 6.5 times more likely to have at least one primary care contact (p <0.001). One to 30 days prior to diagnosis, contacts relating to blood tests, fungal conditions, respiratory tract infections, urinary conditions, vomiting, and weight were independently associated with Type 1 diabetes, as were contacts relating to blood tests, between 91 and 180 days prior to diagnosis. Children with a contact up to a month prior to diagnosis, relating to respiratory tract infections, antibiotic prescriptions, and vomiting, were more likely to present in DKA, as were boys (p = 0.047). Conclusion There are opportunities in primary care for an earlier diagnosis of Type 1 diabetes in childhood. These data could be used to create a predictive diagnostic tool, as a potential aid for primary care health professionals, to prevent presentation in DKA.
- 11 December 2017
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 74 (4) , 513-520
The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures
Pregnancy prevention programmes (PPPs) exist for some medicines known to be highly teratogenic. It is increasingly recognised that the impact of these risk minimisation measures requires periodic evaluation. This study aimed to assess the extent to which some of the data needed to monitor the effectiveness of PPPs may be present in European healthcare databases.
- 11 December 2017
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 74 (4) , 513-520
The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures
Pregnancy prevention programmes (PPPs) exist for some medicines known to be highly teratogenic. It is increasingly recognised that the impact of these risk minimisation measures requires periodic evaluation. This study aimed to assess the extent to which some of the data needed to monitor the effectiveness of PPPs may be present in European healthcare databases.
- Open Access
- 23 May 2016
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 70 (12) , 1184-1190
Effects of an air pollution personal alert system on health service usage in a high-risk general population: a quasi-experimental study using linked data
Background There is no evidence to date on whether an intervention alerting people to high levels of pollution is effective in reducing health service utilisation. We evaluated alert accuracy and the effect of a targeted personal air pollution alert system, airAware, on emergency hospital admissions, emergency department attendances, general practitioner contacts and prescribed medications. Methods Quasi-experimental study describing accuracy of alerts compared with pollution triggers; and comparing relative changes in healthcare utilisation in the intervention group to those who did not sign-up. Participants were people diagnosed with asthma, chronic obstructive pulmonary disease (COPD) or coronary heart disease, resident in an industrial area of south Wales and registered patients at 1 of 4 general practices. Longitudinal anonymised record linked data were modelled for participants and non-participants, adjusting for differences between groups. Results During the 2-year intervention period alerts were correctly issued on 208 of 248 occasions; sensitivity was 83.9% (95% CI 78.8% to 87.9%) and specificity 99.5% (95% CI 99.3% to 99.6%). The intervention was associated with a 4-fold increase in admissions for respiratory conditions (incidence rate ratio (IRR) 3.97; 95% CI 1.59 to 9.93) and a near doubling of emergency department attendance (IRR=1.89; 95% CI 1.34 to 2.68). Conclusions The intervention was associated with increased emergency admissions for respiratory conditions. While findings may be context specific, evidence from this evaluation questions the benefits of implementing near real-time personal pollution alert systems for high-risk individuals.
- 23 May 2016
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 70 (12) , 1184-1190
Open AccessEffects of an air pollution personal alert system on health service usage in a high-risk general population: a quasi-experimental study using linked data
Background There is no evidence to date on whether an intervention alerting people to high levels of pollution is effective in reducing health service utilisation. We evaluated alert accuracy and the effect of a targeted personal air pollution alert system, airAware, on emergency hospital admissions, emergency department attendances, general practitioner contacts and prescribed medications. Methods Quasi-experimental study describing accuracy of alerts compared with pollution triggers; and comparing relative changes in healthcare utilisation in the intervention group to those who did not sign-up. Participants were people diagnosed with asthma, chronic obstructive pulmonary disease (COPD) or coronary heart disease, resident in an industrial area of south Wales and registered patients at 1 of 4 general practices. Longitudinal anonymised record linked data were modelled for participants and non-participants, adjusting for differences between groups. Results During the 2-year intervention period alerts were correctly issued on 208 of 248 occasions; sensitivity was 83.9% (95% CI 78.8% to 87.9%) and specificity 99.5% (95% CI 99.3% to 99.6%). The intervention was associated with a 4-fold increase in admissions for respiratory conditions (incidence rate ratio (IRR) 3.97; 95% CI 1.59 to 9.93) and a near doubling of emergency department attendance (IRR=1.89; 95% CI 1.34 to 2.68). Conclusions The intervention was associated with increased emergency admissions for respiratory conditions. While findings may be context specific, evidence from this evaluation questions the benefits of implementing near real-time personal pollution alert systems for high-risk individuals.
- Open Access
- 28 October 2014
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 122 (7) , 1010-1020
Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population‐based study in six European regions
Objective: To explore the prescribing patterns of selective serotonin reuptake inhibitors (SSRIs) before, during and after pregnancy in six European population‐based databases.Design: Descriptive drug utilisation study.Setting: Six electronic healthcare databases in Denmark, the Netherlands, Italy (Emilia Romagna/Tuscany), Wales and the rest of the UK.Population: All women with a pregnancy ending in a live or stillbirth starting and ending between 2004 and 2010.Methods: A common protocol was implemented across databases to identify SSRI prescriptions issued (UK) or dispensed (non‐UK) in the year before, during or in the year following pregnancy.Main outcome measures: The percentage of deliveries in which the woman received an SSRI prescription in the year before, during or in the year following pregnancy. We also compared the choice of SSRIs and changes in prescribing over the study period.Results: In total, 721 632 women and 862 943 deliveries were identified. In the year preceding pregnancy, the prevalence of SSRI prescribing was highest in Wales [9.6%; 95% confidence interval (CI95), 9.4–9.8%] and lowest in Emilia Romagna (3.3%; CI95, 3.2–3.4%). During pregnancy, SSRI prescribing had dropped to between 1.2% (CI95, 1.1–1.3%) in Emilia Romagna and 4.5% (CI95, 4.3–4.6%) in Wales. The higher UK pre‐pregnancy prescribing rates resulted in higher first trimester exposures. After pregnancy, SSRI prescribing increased most rapidly in the UK. Paroxetine was more commonly prescribed in the Netherlands and Italian regions than in Denmark and the UK.Conclusions: The higher SSRI prescribing rates in the UK, compared with other European regions, raise questions about differences in the prevalence and severity of depression and its management in pregnancy across Europe.
- 28 October 2014
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 122 (7) , 1010-1020
Open AccessSelective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population‐based study in six European regions
Objective: To explore the prescribing patterns of selective serotonin reuptake inhibitors (SSRIs) before, during and after pregnancy in six European population‐based databases.Design: Descriptive drug utilisation study.Setting: Six electronic healthcare databases in Denmark, the Netherlands, Italy (Emilia Romagna/Tuscany), Wales and the rest of the UK.Population: All women with a pregnancy ending in a live or stillbirth starting and ending between 2004 and 2010.Methods: A common protocol was implemented across databases to identify SSRI prescriptions issued (UK) or dispensed (non‐UK) in the year before, during or in the year following pregnancy.Main outcome measures: The percentage of deliveries in which the woman received an SSRI prescription in the year before, during or in the year following pregnancy. We also compared the choice of SSRIs and changes in prescribing over the study period.Results: In total, 721 632 women and 862 943 deliveries were identified. In the year preceding pregnancy, the prevalence of SSRI prescribing was highest in Wales [9.6%; 95% confidence interval (CI95), 9.4–9.8%] and lowest in Emilia Romagna (3.3%; CI95, 3.2–3.4%). During pregnancy, SSRI prescribing had dropped to between 1.2% (CI95, 1.1–1.3%) in Emilia Romagna and 4.5% (CI95, 4.3–4.6%) in Wales. The higher UK pre‐pregnancy prescribing rates resulted in higher first trimester exposures. After pregnancy, SSRI prescribing increased most rapidly in the UK. Paroxetine was more commonly prescribed in the Netherlands and Italian regions than in Denmark and the UK.Conclusions: The higher SSRI prescribing rates in the UK, compared with other European regions, raise questions about differences in the prevalence and severity of depression and its management in pregnancy across Europe.